Deriglidole
Alternative Names: SL 840418; SL 860714; SL 860715Latest Information Update: 02 Jun 1995
At a glance
- Originator Sanofi-Synthelabo
- Class Antihyperglycaemics; Imidazoles; Indoles; Small molecules
- Mechanism of Action Alpha 2 adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 02 Jun 1995 Discontinued-II for Type-2 diabetes mellitus in France (PO)